AUD 1.47
(4.26%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 12.17 Million AUD | -11.13% |
2022 | 13.7 Million USD | -49.0% |
2021 | 26.86 Million AUD | -19.97% |
2020 | 33.56 Million AUD | 219.05% |
2019 | 10.52 Million AUD | -34.47% |
2018 | 16.05 Million AUD | 435.48% |
2017 | 2.99 Million AUD | -13.46% |
2016 | 3.46 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 7.7 Million USD | 0.0% |
2024 Q1 | 7.7 Million USD | -7.25% |
2023 Q1 | 8.13 Million USD | -40.65% |
2023 FY | 12.17 Million AUD | -11.13% |
2023 Q3 | 8.3 Million USD | 2.18% |
2023 Q2 | 8.13 Million USD | 0.0% |
2023 Q4 | 8.3 Million USD | 0.0% |
2022 Q4 | 13.7 Million USD | 0.0% |
2022 FY | 13.7 Million USD | -49.0% |
2022 Q3 | 13.7 Million USD | -21.13% |
2022 Q1 | 17.37 Million USD | -35.33% |
2022 Q2 | 17.37 Million USD | 0.0% |
2021 Q3 | 26.86 Million USD | 11.66% |
2021 FY | 26.86 Million AUD | -19.97% |
2021 Q1 | 24.05 Million USD | -44.8% |
2021 Q4 | 26.86 Million AUD | 0.0% |
2021 Q2 | 24.05 Million USD | 0.0% |
2020 Q4 | 43.58 Million AUD | 29.84% |
2020 FY | 33.56 Million AUD | 219.05% |
2020 Q1 | 19.05 Million USD | 81.08% |
2020 Q2 | 19.05 Million USD | 0.0% |
2020 Q3 | 33.56 Million USD | 76.19% |
2019 Q4 | 10.52 Million USD | 0.0% |
2019 FY | 10.52 Million AUD | -34.47% |
2019 Q3 | 10.52 Million USD | 54.92% |
2019 Q2 | 6.79 Million USD | 0.0% |
2019 Q1 | 6.79 Million USD | 29.88% |
2018 FY | 16.05 Million AUD | 435.48% |
2018 Q1 | - USD | 0.0% |
2018 Q3 | 5.22 Million USD | 0.0% |
2018 Q4 | 5.22 Million USD | 0.0% |
2017 FY | 2.99 Million AUD | -13.46% |
2016 FY | 3.46 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
4DMedical Limited | 120.01 Million AUD | 89.855% |
Adherium Limited | 9.88 Million AUD | -23.15% |
Aroa Biosurgery Limited | 101.82 Million AUD | 88.042% |
Atomo Diagnostics Limited | 11.37 Million AUD | -7.004% |
Anteris Technologies Ltd | 45.7 Million AUD | 73.357% |
Control Bionics Limited | 9.02 Million AUD | -34.88% |
CardieX Limited | 12.64 Million AUD | 3.745% |
Compumedics Limited | 40.35 Million AUD | 69.83% |
Cochlear Limited | 2.74 Billion AUD | 99.556% |
CleanSpace Holdings Limited | 26.05 Million AUD | 53.262% |
Cyclopharm Limited | 45.91 Million AUD | 73.481% |
EMVision Medical Devices Ltd | 23.97 Million AUD | 49.206% |
Nova Eye Medical Limited | 29.88 Million AUD | 59.253% |
HeraMED Limited | 2.95 Million AUD | -312.455% |
ImpediMed Limited | 46.98 Million AUD | 74.086% |
InhaleRx Limited | 1.57 Million AUD | -672.158% |
LBT Innovations Limited | 7.93 Million AUD | -53.525% |
Micro-X Limited | 26.89 Million AUD | 54.727% |
Neurotech International Limited | 12.21 Million AUD | 0.306% |
OncoSil Medical Limited | 6.71 Million AUD | -81.234% |
PolyNovo Limited | 109.16 Million AUD | 88.846% |
Respiri Limited | 6.19 Million AUD | -96.676% |
SomnoMed Limited | 69.8 Million AUD | 82.557% |
Universal Biosensors, Inc. | 30.12 Million AUD | 59.575% |
Uscom Limited | 5.13 Million AUD | -137.136% |
Visioneering Technologies, Inc. | 11.2 Million AUD | -8.662% |